• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Updates, 26-08-2025: General Updates

    26-08-2025 | 09:36 am

    Aurobindo Pharma's subsidiary CuraTeQ Biologics secured UK approval for its biosimilar Dazublys™ (trastuzumab). This is CuraTeQ's fourth biosimilar approved in the UK, following prior EU approval, expanding key market access.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited